Skip to main content
. 2019 Aug 28;317(5):F1142–F1153. doi: 10.1152/ajprenal.00276.2019

Table 1.

Baseline characteristics and single kidney function in study groups

Lean MetS Lean + RAS MetS + RAS
Body weight, kgd 56.0 ± 6.2 90.5 ± 6.0a 50.8 ± 6.4 91.2 ± 3.6a
Mean arterial pressure, mmHg 98.4 ± 8.9 118.6 ± 15.1a 119.6 ± 11.6a 128.4 ± 8.4a
Degree of stenosis, %e 0 0 72.3 ± 10.2a,b 77.5 ± 11.3a,b
Total cholesterol, mg/dld 82.8 ± 7.8 422.2 ± 40.1a 85.5 ± 6.7b 417.3 ± 57.8a,c
LDL cholesterol, mg/dld 33.4 ± 6.5 361.1 ± 63.4a 66.8 ± 32.7b 296.7 ± 52.8a,c
Triglycerides, mg/dld 7.5 ± 1.9 17.3 ± 7.9a 6.2 ± 1.2b 13.3 ± 5.2a,c
Fasting glucose, mg/dld 129.5 ± 14.7 113.0 ± 8.9 114.7 ± 12.0 108.5 ± 12.8
Fasting insulin, mU/mld 0.4 [0.3–0.5] 0.7 [0.7–0.8]a 0.4 [0.3–0.4]b 0.8 [0.7–0.8]a,c
HOMA-IR scored 0.6 [0.6–0.7] 1.9 [1.5–1.9]a 0.6 [0.6–0.7]b 1.8 [1.7–1.9]a,c
Renal volume, mld,e 125.9 ± 12.3 217.9 ± 11.4a 79.5 ± 10.3a,b 169.1 ± 7.7a,b,c
Renal blood flow, ml/mind,e 522.2 ± 18.2 872.0 ± 87.8a 331.9 ± 22.3a,b 651.5 ± 11.2a,b,c
Glomerular filtration rate, ml/mind,e 74.7 ± 4.5 148.1 ± 6.1a 39.2 ± 6.0a,b 94.2 ± 4.8a,b,c

Values are means ± SE; n = 7 each. Lean, lean diet fed; MetS, metabolic syndrome; RAS, renal artery stenosis; HOMA-IR, homeostasis model assessment of insulin resistance.

a

P < 0.05 vs. the Lean group;

b

P < 0.05 vs. the MetS group;

c

P < 0.05 vs. the Lean + RAS group.

d

MetS: significant effect of MetS (two-way ANOVA);

e

Ischemia: significant effect of ischemia (two-way ANOVA).